5-MAPDI
Clinical data
ATC code
  • none
Identifiers
  • 1-(2,3-Dihydro-1H-inden-5-yl)-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC13H19N
Molar mass189.297 g·mol−1
3D model (JSmol)
  • CNC(Cc1ccc2c(c1)CCC2)C
  • InChI=1S/C13H19N/c1-10(14-2)8-11-6-7-12-4-3-5-13(12)9-11/h6-7,9-10,14H,3-5,8H2,1-2H3
  • Key:MHBKJTHGGWQKSG-UHFFFAOYSA-N

5-MAPDI (also known as Indanylmethylaminopropane or IMP) is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to dihydrobenzofuran derivatives such as 5-MAPDB and 6-MAPDB, and has been sold as a designer drug. It has reportedly been sold over grey-market websites since around 2014, although the first definitive identification was not made until September 2016 by a forensic laboratory in Slovenia.[1]

See also

References

  1. ^ European Monitoring Center for Drugs and Drug Addiction – Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA
Categories